1. Home
  2. TOWN vs IMNM Comparison

TOWN vs IMNM Comparison

Compare TOWN & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TowneBank

TOWN

TowneBank

N/A

Current Price

$37.04

Market Cap

2.7B

Sector

Finance

ML Signal

N/A

Logo Immunome Inc.

IMNM

Immunome Inc.

N/A

Current Price

$24.04

Market Cap

2.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TOWN
IMNM
Founded
1998
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.2B
IPO Year
1999
2020

Fundamental Metrics

Financial Performance
Metric
TOWN
IMNM
Price
$37.04
$24.04
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$31.22
AVG Volume (30 Days)
514.3K
2.1M
Earning Date
01-28-2026
03-18-2026
Dividend Yield
2.91%
N/A
EPS Growth
2.79
N/A
EPS
2.21
N/A
Revenue
$811,780,000.00
$9,679,000.00
Revenue This Year
$35.38
N/A
Revenue Next Year
$7.01
$11.53
P/E Ratio
$16.78
N/A
Revenue Growth
16.92
N/A
52 Week Low
$29.43
$5.15
52 Week High
$38.01
$27.65

Technical Indicators

Market Signals
Indicator
TOWN
IMNM
Relative Strength Index (RSI) 63.76 57.35
Support Level $34.34 $23.86
Resistance Level $37.69 $27.65
Average True Range (ATR) 1.04 1.63
MACD 0.13 -0.08
Stochastic Oscillator 89.88 62.94

Price Performance

Historical Comparison
TOWN
IMNM

About TOWN TowneBank

Towne Bank is a financial services company that places special emphasis on serving the financial needs of individuals, commercial enterprises, and professionals, offering retail and commercial banking services to numerous markets in Virginia and North Carolina. The company has three reportable segments: the Banking Segment provides loan and deposit services to retail and commercial customers and provides commercial mortgage brokerage services and investment and asset management services, and the Realty Segment provides residential real estate services and mortgage loans. It also provides resort property management and residential and commercial title insurance, and the Insurance Segment provides a wide array of insurance products, including property, casualty, life, and health insurance.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: